MRMS AXELERATE
LIVE

Serial Number

79249366

Owner

Bruker Daltonik GmbH

Attorney

PAUL G. NOVAK

Filing Date

Nov 16, 2018

Add to watchlist:

No watchlists yet
View on USPTO

MRMS AXELERATE Trademark

Serial Number: 79249366 • Registration: 5940654

MRMS AXELERATE is a trademark filed by Bruker Daltonik GmbH on November 16, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Bruker Daltonik GmbH

Fahrenheitstr. 4
28359 Bremen , DE

Entity Type: 99

Bruker Daltonics GmbH & Co. KG (2 trademarks)

Fahrenheitstraße 4

Entity Type: 28

Trademark Details

Filing Date

November 16, 2018

Registration Date

December 24, 2019

Published for Opposition

October 8, 2019

Goods & Services

[ Scientific apparatus in the nature of mass spectrometers and parts therefor, in particular ion cyclotron resonance mass spectrometers and imaging mass spectrometers and structural parts therefor; devices for generating gas-phase ions, in particular devices for ionization by means of electrospray and laser desorption, namely matrix-assisted laser desorption; ] computer programs and computer software for operating and controlling a mass spectrometer; computer programs and computer software for processing, evaluating and displaying data acquired using a mass spectrometer

Scientific analysis services featuring mass spectrometric high-throughput analyses of samples of complex composition in the nature of biological samples and crude oil samples, mass spectrometric determinations of the isotopic fine structure of molecules in a sample of complex composition, and mass spectrometric identification of biomarkers in samples of complex composition based on the determination of the exact masses and isotope ratios

[ Medical-diagnostic testing and analysis services featuring mass spectrometric high-throughput analyses of clinical samples in the nature of body tissue and body fluids such as blood and urine, mass spectrometric determinations of the isotopic fine structure of molecules in a clinical sample, and mass spectrometric identification of biomarkers in clinical samples based on the determination of the exact masses and isotope ratios ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 18, 2026 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 18, 2026 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 6, 2026 APRE
TEAS SECTION 71 & 15 RECEIVED
Dec 12, 2025 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 24, 2024 REM3
CHANGE OF OWNER RECEIVED FROM IB
Nov 19, 2021 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 6, 2020 FICS
FINAL DISPOSITION PROCESSED
Apr 6, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 24, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 24, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 8, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Oct 5, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2019 NONP
ASSIGNED TO LIE
Sep 2, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2019 TROA
REFUSAL PROCESSED BY IB
Apr 5, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 18, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 18, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 8, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 7, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 20, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 19, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 10, 2019 REPR